Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2023 Q2- Text added to 2023 Q3
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
New words:
AACR, adenocarcinoma, biology, body, build, colorectal, Conference, core, defeat, dissolution, ductal, durability, East, fact, GI, GMP, immunogenicity, Immunotherapy, magnitude, Middle, monotherapy, mutant, orchestrate, pancreatic, PDAC, perception, potency, power, randomized, relapse, runway, schoolhouse, SITC, solid, stimulate, unique
Valuein 2023 Q2 filing- Value in 2023 Q3 filing
Original filings
Filing view